st james's oncology spc holdings ltd
st james's oncology spc holdings ltd Company Information
Company Number
05094407
Next Accounts
Sep 2025
Shareholders
consolidated investment holdings ltd
Group Structure
View All
Industry
Hospital activities
Registered Address
c/o albany spc services ltd, 3rd floor, manchester, M1 4HB
Website
lendlease.comst james's oncology spc holdings ltd Estimated Valuation
Pomanda estimates the enterprise value of ST JAMES'S ONCOLOGY SPC HOLDINGS LTD at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
st james's oncology spc holdings ltd Estimated Valuation
Pomanda estimates the enterprise value of ST JAMES'S ONCOLOGY SPC HOLDINGS LTD at £0 based on an EBITDA of £0 and a 3.74x industry multiple (adjusted for size and gross margin).
st james's oncology spc holdings ltd Estimated Valuation
Pomanda estimates the enterprise value of ST JAMES'S ONCOLOGY SPC HOLDINGS LTD at £40m based on Net Assets of £15.8m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
St James's Oncology Spc Holdings Ltd Overview
St James's Oncology Spc Holdings Ltd is a live company located in manchester, M1 4HB with a Companies House number of 05094407. It operates in the hospital activities sector, SIC Code 86101. Founded in April 2004, it's largest shareholder is consolidated investment holdings ltd with a 100% stake. St James's Oncology Spc Holdings Ltd is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
St James's Oncology Spc Holdings Ltd Health Check
There is insufficient data available to calculate a health check for St James'S Oncology Spc Holdings Ltd. Company Health Check FAQs
0 Strong
0 Regular
3 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- St James's Oncology Spc Holdings Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Employees
with 1 employees, this is below the industry average (50)
- St James's Oncology Spc Holdings Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- St James's Oncology Spc Holdings Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- St James's Oncology Spc Holdings Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (29 weeks)
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 58.7%, this is a higher level of debt than the average (49.4%)
- - St James's Oncology Spc Holdings Ltd
- - Industry AVG
ST JAMES'S ONCOLOGY SPC HOLDINGS LTD financials
St James'S Oncology Spc Holdings Ltd's latest turnover from December 2023 is 0 and the company has net assets of £15.8 million. According to their latest financial statements, we estimate that St James'S Oncology Spc Holdings Ltd has 1 employee and maintains cash reserves of £51 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 3,339,000 | 3,583,000 | 3,538,000 | 3,141,000 | 2,773,000 | 2,539,000 | 2,559,000 | 2,577,000 | 2,557,000 | 2,558,000 | 2,540,000 | 2,520,000 | 2,457,000 | 2,479,000 | 2,507,000 |
| Interest Receivable | 3,340,000 | 3,583,000 | 3,538,000 | 3,141,000 | 2,773,000 | 2,539,000 | 2,559,000 | 2,577,000 | 2,557,000 | 2,558,000 | 2,540,000 | 2,520,000 | 2,457,000 | 2,479,000 | 2,507,000 |
| Pre-Tax Profit | 1,000 | 39,150,000 | |||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | 1,000 | 39,150,000 | |||||||||||||
| Dividends Paid | 23,380,000 | ||||||||||||||
| Retained Profit | 1,000 | 15,770,000 | |||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 15,870,000 | 15,870,000 | 15,870,000 | 15,870,000 | 15,870,000 | 15,870,000 | 15,870,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 |
| Debtors (Due After 1 year) | 17,688,000 | 20,553,000 | 28,723,000 | 23,130,000 | 17,877,000 | 19,284,000 | 19,108,000 | 20,142,000 | 19,156,000 | 19,197,000 | 19,740,000 | 19,117,000 | 19,167,000 | 19,213,000 | 19,348,000 |
| Total Fixed Assets | 33,558,000 | 36,423,000 | 44,593,000 | 39,000,000 | 33,747,000 | 35,154,000 | 34,978,000 | 20,192,000 | 19,206,000 | 19,247,000 | 19,790,000 | 19,167,000 | 19,217,000 | 19,263,000 | 19,398,000 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 4,721,000 | 8,467,000 | 2,190,000 | 4,246,000 | 6,358,000 | 2,177,000 | 825,000 | 1,158,000 | 1,576,000 | 1,391,000 | 1,175,000 | 1,618,000 | 884,000 | 746,000 | 2,252,000 |
| Misc Debtors | |||||||||||||||
| Cash | 51,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | ||||||||
| misc current assets | |||||||||||||||
| total current assets | 4,772,000 | 8,517,000 | 2,240,000 | 4,296,000 | 6,408,000 | 2,227,000 | 875,000 | 1,158,000 | 1,576,000 | 1,391,000 | 1,175,000 | 1,618,000 | 884,000 | 746,000 | 2,252,000 |
| total assets | 38,330,000 | 44,940,000 | 46,833,000 | 43,296,000 | 40,155,000 | 37,381,000 | 35,853,000 | 21,350,000 | 20,782,000 | 20,638,000 | 20,965,000 | 20,785,000 | 20,101,000 | 20,009,000 | 21,650,000 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 4,771,000 | 8,517,000 | 2,240,000 | 4,296,000 | 6,408,000 | 2,227,000 | 875,000 | 1,158,000 | |||||||
| other short term finances | 1,576,000 | 1,391,000 | 534,000 | 983,000 | 270,000 | 135,000 | 1,591,000 | ||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 641,000 | 635,000 | 614,000 | 611,000 | 661,000 | |||
| total current liabilities | 4,821,000 | 8,567,000 | 2,290,000 | 4,346,000 | 6,458,000 | 2,277,000 | 925,000 | 1,158,000 | 1,576,000 | 1,391,000 | 1,175,000 | 1,618,000 | 884,000 | 746,000 | 2,252,000 |
| loans | 17,688,000 | 20,553,000 | 28,723,000 | 23,130,000 | 17,877,000 | 19,284,000 | 19,108,000 | 20,142,000 | 19,156,000 | 19,197,000 | 19,740,000 | 19,117,000 | 19,167,000 | 19,213,000 | 19,348,000 |
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 17,688,000 | 20,553,000 | 28,723,000 | 23,130,000 | 17,877,000 | 19,284,000 | 19,108,000 | 20,142,000 | 19,156,000 | 19,197,000 | 19,740,000 | 19,117,000 | 19,167,000 | 19,213,000 | 19,348,000 |
| total liabilities | 22,509,000 | 29,120,000 | 31,013,000 | 27,476,000 | 24,335,000 | 21,561,000 | 20,033,000 | 21,300,000 | 20,732,000 | 20,588,000 | 20,915,000 | 20,735,000 | 20,051,000 | 19,959,000 | 21,600,000 |
| net assets | 15,821,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 |
| total shareholders funds | 15,821,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 15,820,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 | 50,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | -6,611,000 | -1,893,000 | 3,537,000 | 3,141,000 | 2,774,000 | 1,528,000 | -1,367,000 | 568,000 | 144,000 | -327,000 | 180,000 | 684,000 | 92,000 | -1,641,000 | 21,600,000 |
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 50,000 | -641,000 | 6,000 | 21,000 | 3,000 | -50,000 | 661,000 | ||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | 6,611,000 | 1,893,000 | -3,537,000 | -3,141,000 | -2,774,000 | -1,528,000 | 1,417,000 | -568,000 | -144,000 | -314,000 | -174,000 | -663,000 | -89,000 | 1,591,000 | -20,939,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 15,820,000 | 50,000 | |||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -3,746,000 | 6,277,000 | -2,056,000 | -2,112,000 | 4,181,000 | 1,352,000 | -283,000 | 1,158,000 | |||||||
| Other Short Term Loans | -1,576,000 | 185,000 | 857,000 | -449,000 | 713,000 | 135,000 | -1,456,000 | 1,591,000 | |||||||
| Long term loans | -2,865,000 | -8,170,000 | 5,593,000 | 5,253,000 | -1,407,000 | 176,000 | -1,034,000 | 986,000 | -41,000 | -543,000 | 623,000 | -50,000 | -46,000 | -135,000 | 19,348,000 |
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 1,000 | ||||||||||||||
| cash flow from financing | -6,610,000 | -1,893,000 | 3,537,000 | 3,141,000 | 2,774,000 | 1,528,000 | -1,317,000 | 568,000 | 144,000 | 314,000 | 174,000 | 663,000 | 89,000 | -1,591,000 | 20,989,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 1,000 | 50,000 | |||||||||||||
| overdraft | |||||||||||||||
| change in cash | 1,000 | 50,000 |
st james's oncology spc holdings ltd Credit Report and Business Information
St James's Oncology Spc Holdings Ltd Competitor Analysis
Perform a competitor analysis for st james's oncology spc holdings ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mature companies, companies in M 1 area or any other competitors across 12 key performance metrics.
st james's oncology spc holdings ltd Ownership
ST JAMES'S ONCOLOGY SPC HOLDINGS LTD group structure
St James'S Oncology Spc Holdings Ltd has 2 subsidiary companies.
Ultimate parent company
1 parent
ST JAMES'S ONCOLOGY SPC HOLDINGS LTD
05094407
2 subsidiaries
st james's oncology spc holdings ltd directors
St James'S Oncology Spc Holdings Ltd currently has 6 directors. The longest serving directors include Mr Christopher Solley (Oct 2012) and Mr Barry Millsom (Sep 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Solley | England | 54 years | Oct 2012 | - | Director |
| Mr Barry Millsom | England | 50 years | Sep 2014 | - | Director |
| Mr Johan Potgieter | England | 44 years | Jan 2021 | - | Director |
| Mr Michael Williams | England | 45 years | Jan 2021 | - | Director |
| Mr Johan Potgieter | United Kingdom | 44 years | Jan 2021 | - | Director |
| Mr Mathew Grace | England | 33 years | Feb 2025 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
15.8m
0%
total assets
38.3m
-0.15%
cash
51k
+0.02%
net assets
Total assets minus all liabilities
st james's oncology spc holdings ltd company details
company number
05094407
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
April 2004
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
catalyst healthcare (leeds) holdings limited (November 2011)
broomco (3446) limited (June 2004)
accountant
-
auditor
JOHNSTON CARMICHAEL
address
c/o albany spc services ltd, 3rd floor, manchester, M1 4HB
Bank
BANK OF SCOTLAND
Legal Advisor
STEPHENSON HARWOOD LLP
st james's oncology spc holdings ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to st james's oncology spc holdings ltd.
st james's oncology spc holdings ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ST JAMES'S ONCOLOGY SPC HOLDINGS LTD. This can take several minutes, an email will notify you when this has completed.
st james's oncology spc holdings ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
